Agonist News and Research

RSS
Diabetes drug shows potential in slowing prostate cancer progression

Diabetes drug shows potential in slowing prostate cancer progression

GLP-1 weight loss drugs leave users low on key nutrients, study finds

GLP-1 weight loss drugs leave users low on key nutrients, study finds

Online obesity clinic achieves clinical trial-level weight loss with lower semaglutide doses

Online obesity clinic achieves clinical trial-level weight loss with lower semaglutide doses

GLP-1 drugs linked to significant BMI reduction in children with severe obesity

GLP-1 drugs linked to significant BMI reduction in children with severe obesity

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

Diabetes drug shows promise for treating prostate cancer

Diabetes drug shows promise for treating prostate cancer

Monell study offers renewed hope for people living with Bardet-Biedl Syndrome

Monell study offers renewed hope for people living with Bardet-Biedl Syndrome

Mid afternoon inhaler use may improve nighttime asthma control

Mid afternoon inhaler use may improve nighttime asthma control

Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight loss

Study shows minimal lean muscle mass loss with GLP-1 and GLP-1/GIP therapy for weight loss

Semaglutide linked to higher risk of vision problems, FDA data analysis shows

Semaglutide linked to higher risk of vision problems, FDA data analysis shows

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

New trial shows oral semaglutide reduces cardiovascular events in diabetes patients

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes

Dopamine neurons play a central role in sustaining hedonic eating

Dopamine neurons play a central role in sustaining hedonic eating

Novel cyclic peptide antagonist can be a promising therapeutic approach for MASH

Novel cyclic peptide antagonist can be a promising therapeutic approach for MASH

Tirzepatide helps people without diabetes lose 13% body weight in real-world study

Tirzepatide helps people without diabetes lose 13% body weight in real-world study

Study reveals the role of transcription factors as therapeutic gateways in MAFLD

Study reveals the role of transcription factors as therapeutic gateways in MAFLD

Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liver

Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liver

Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetes

Study shows benefits of GLP-1 drugs for kidney transplant recipients with type 2 diabetes

Surgery first strategy could lead to better weight loss outcomes

Surgery first strategy could lead to better weight loss outcomes

New study confirms GLP-1 medications are safe for mental health in diabetes

New study confirms GLP-1 medications are safe for mental health in diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.